1-68439224-G-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP4PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000329.3(RPE65):c.825C>A (p.Tyr275Ter) variant is a nonsense variant that introduces a premature stop codon into exon 8 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype including congenital night blindness (0.5 pts), extinguished rod ERG responses (0.5 pts), previous exome sequencing that did not provide an alternative explanation for visual impairment (2 pts), symptomatic onset between birth and age five years (1 pt), retinal degeneration with attenuated vessels (0.5 pts), and extinguished cone ERG responses (1 pt), which together are specific for RPE65-related recessive retinopathy (5.5 points, PMID:31273949, PP4). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PVS1, PM2_Supporting, PP4. (VCEP specifications version 1.0.0; date of approval 09/21/2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA340745588/MONDO:0100368/120
Frequency
Consequence
NM_000329.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
RPE65-related recessive retinopathy Pathogenic:1
The NM_000329.3(RPE65):c.825C>A (p.Tyr275Ter) variant is a nonsense variant that introduces a premature stop codon into exon 8 of 14, and is predicted to lead to nonsense-mediated decay in a gene in which loss-of-function is an established mechanism of disease (PVS1). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). At least one proband harboring this variant exhibits a phenotype including congenital night blindness (0.5 pts), extinguished rod ERG responses (0.5 pts), previous exome sequencing that did not provide an alternative explanation for visual impairment (2 pts), symptomatic onset between birth and age five years (1 pt), retinal degeneration with attenuated vessels (0.5 pts), and extinguished cone ERG responses (1 pt), which together are specific for RPE65-related recessive retinopathy (5.5 points, PMID: 31273949, PP4). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PVS1, PM2_Supporting, PP4. (VCEP specifications version 1.0.0; date of approval 09/21/2023). -
Leber congenital amaurosis 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.